Vectura Signs Agreement with Sandoz to Develop Generic Combination Therapy for Asthma and COPD in the U.S.
News
A generic version of an existing inhaled combination therapy for asthma and chronic obstructive pulmonary disease (COPD) will be developed in the United States under an agreement between Vectura Group subsidiary Jagotec ... Read more